Skip to main content

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Comparative and Clinical Medicine

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1582006

Septal-to-Basal Ventricular peak activation time determined by vectorcardiography as a potential new pre-screening parameter for preclinical dilated cardiomyopathy in

Provisionally accepted
Margot Gheeraert Margot Gheeraert 1*Gerhard Wess Gerhard Wess 2Gitte Mampaey Gitte Mampaey 1Jenny Eberhard Jenny Eberhard 2Peter Gheeraert Peter Gheeraert 1Jan De Pooter Jan De Pooter 1Luc Duchateau Luc Duchateau 1Pascale Smets Pascale Smets 1
  • 1 Ghent University, Ghent, Belgium
  • 2 Faculty of Veterinary Medicine, Ludwig-Maximilians-University of Munich, Munich, Bavaria, Germany

The final, formatted version of the article will be published soon.

    Background: Early diagnosis of preclinical dilated cardiomyopathy (DCM) remains challenging in primary veterinary medicine due to the need for echocardiography and 24-hour Holter electrocardiogram (ECG) recording. A readily available pre-screening tool to identify dogs at high risk could optimize current screening practice. Electrocardiographic methods have not been investigated for this purpose. Vectorcardiographic Septal-to-Basal Ventricular peak activation time (SB-VPAT) was investigated in a preliminary pilot study. We hypothesize that SB-VPAT is a sensitive parameter for detection of systolic dysfunction due to preclinical DCM stage B2 and correlates with left ventricular size and function in Doberman Pinschers. Animals: 122 Doberman Pinschers (98 control and 24 with systolic dysfunction due to preclinical DCM). Methods: Prospective cross-sectional study. All dogs underwent echocardiography, three-minute six or 12-lead ECG and RELF ECG. Based on echocardiographic evaluation, dogs were classified into a control group (including apparently healthy dogs and dogs with ventricular arrhythmia's only) or a group with systolic dysfunction associated with preclinical DCM stage B2. ROC curves of SB-VPAT and its correlation with left ventricular size and function were analyzed.Results: SB-VPAT ≥ 33.5 ms had a sensitivity of 94.4% and specificity of 83.6% for the detection of systolic dysfunction due to preclinical DCM stage B2 (AUC 0.954, SD 0.022). Furthermore, SB-VPAT was strongly correlated with the left ventricular systolic diameter, systolic volume index and moderately inversely correlated with EF.Conclusions and clinical importance: In conclusion, SB-VPAT is a sensitive parameter to detect systolic dysfunction associated with preclinical DCM stage B2. Further investigation of its diagnostic potential compared to or in combination with other tools in a primary care veterinary setting is warranted.

    Keywords: ECG, VCG, canine, Vector, RELF

    Received: 23 Feb 2025; Accepted: 24 Mar 2025.

    Copyright: © 2025 Gheeraert, Wess, Mampaey, Eberhard, Gheeraert, De Pooter, Duchateau and Smets. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Margot Gheeraert, Ghent University, Ghent, Belgium

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more